The dictates of the in vitro diagnostic regulation (IVDR) and “bureaucratic” issues are dampening the industry’s innovation ...

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to ...

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) ...

Clairity has concluded a $43m funding round, allowing it to advance commercialisation for its AI-powered breast cancer ...

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering ...

Boston Scientific has entered an agreement with Siemens Healthineers to push forward commercialisation activities for the ...

Cornerstone Robotics has raised around $200m in its funding round to expedite commercialisation plans and propel technology ...

InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic ...

The FDA has granted 510(k) clearance to Augmedics’ new augmented reality (AR) headset, X2, designed for use with the xvision ...

Owlet has partnered with Rhapsody to integrate data from its at-home pulse oximeter, BabySat, directly into the patient’s ...